oa SA Pharmaceutical Journal - News

Volume 73, Issue 4
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Extracted from text ... SA Pharmaceutical Journal - May 2006 60 The first ever 3-in-1 combination of a first-line recommended anti-HIV/AIDS treatment regimen has successfully been registered in South Africa. Jerome Smith, CEO of Cipla Medpro, said that the registration of TRIOMUNE comes as a long-awaited medical breakthrough which will simplify the treatment of HIV/ AIDS, resulting in improved patient adherence and ultimately saving more lives and improving the quality of life of those living with HIV/AIDS. TRIOMUNE will also enable the lowering of total costs, including production, storage, transport, dispensing and other healthcare costs, which will help in scaling up access to anti-HIV/AIDS ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error